Colorado Teacher Marks Decade in Remission Following Groundbreaking CAR T-cell Therapy
A Colorado teacher, Amy Cheese, who was given only months to live due to lymphoma, is celebrating 10 years in remission after undergoing CAR T-cell therapy in Omaha, Nebraska. This groundbreaking treatment, which re-engineers a patient's immune cells to fight…
Portland, OR, August 6, 2026 —
Amy Cheese, a teacher from Colorado, is celebrating a significant milestone: 10 years in remission from lymphoma. This achievement comes a decade after she underwent a pioneering CAR T-cell therapy treatment in Omaha, Nebraska, a procedure that was considered a last resort when she was given only months to live.
The life-saving treatment took place at the Fred and Pamela Buffett Cancer Center. CAR T-cell therapy involves re-engineering a patient’s own immune cells to effectively target and combat cancer cells. Cheese participated in a clinical trial for this innovative therapy approximately ten years ago.
This remarkable ten-year remission signifies a major victory against the aggressive nature of her lymphoma. The success of the CAR T-cell therapy trial, in which Amy Cheese was a participant, highlights the potential of this advanced treatment in fighting advanced cancers.
Story summarized from the original created by Brian Mastre, Gray News staff on www.kptv.com, see more information here.
